Core B: Single Cell Protein and RNA Sequencing Core
Core B: Single Cell Protein and RNA Sequencing Core
批准号:
10334092
负责人:
Klaus F. Ley
金额:
$5.35万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-01 至 2022-06-02
关键词:
ATAC-seqAntibodiesAtherosclerosisB-LymphocytesB-cell receptor repertoire sequencingBindingBioinformaticsBiostatistics CoreCardiovascular systemCell CommunicationCellsClinicalCytometryDNA Sequencing FacilityDataEpidemiologistExcisionExperimental DesignsGenomicsGuidelinesHumanImmuneLeukocytesLightManuscriptsMeta-AnalysisMusOligonucleotidesPeptide Sequence DeterminationPeripheral Blood Mononuclear CellPhenotypePostdoctoral FellowProgress ReportsPublishingQuality ControlResearchRunningSamplingServicesShippingSignal TransductionT cell receptor repertoire sequencingT-LymphocyteTissuesVisualizationWorkbasecohortcomputerized data processingdata qualitydesignexperiencehuman dataimprovedmacrophagemonocytesingle cell proteinssingle-cell RNA sequencingtranscriptome sequencing
中文摘要
核心B概述
英文摘要
Core B Summary
Core B serves all 4 projects in this PPG for all RNA sequencing needs, including bulk and single cell RNA-
sequencing (scRNA-Seq), protein sequencing by oligonucleotide-tagged antibodies (Ab-Seq), T- and B-cell
receptor sequencing (TCR-Seq and BCR-Seq) and ATAC-Seq. Core B is responsible for all quality controls
along the workflow. Core B staff consists of wet lab staff and bioinformaticians. They interact with postdocs,
technicians, epidemiologists and PIs from the Human Clinical Cardiovascular and Biostatistics Core (Clinical
Core C) and from each of the four projects. Workflows are established for mouse (macrophages, sorted T
cells) and human (PBMC) cells. Hashtags and antibodies are fully validated, including thresholding, which
improves data quality by eliminating signal from unbound antibody and non-specific antibody binding. The
previous version of this core (core E in the 2016 Hedrick PPG) was the first group world-wide to use scRNA-
Seq in atherosclerosis research. We established and published guidelines for workflows and quality controls in
scRNA-Seq, batch effect, doublet and dead cell removal. Core B provides wet lab and bioinformatics service
plus well-developed interfaces with all 4 projects and core C. For Ab-Seq, we validated a 192 oligonucleotide-
tagged human antibody panel (Biolegend), run on 10x Genomics 5’, which will be used for Ab-Seq in most of
the proposed human studies. For mice, we use the Biolegend 138 mouse antibody panel with 10x Genomics
5’. Using this platform, we have successfully assembled tens of thousands of TCRα and β chain pairs (scTCR-
Seq) and BCR heavy and light chain pairs (scBCR-Seq). All 4 projects use core B. The specific aims are: (1)
To provide the highest quality scRNA-Seq, scAb-Seq, scATAC-Seq, scTCR-Seq and scBCR-Seq for mouse
and human samples, including fully documented and rigorous quality controls, designing and optimizing
antibody panels and advice on all bioinformatics issues. (2) To provide the highest quality bulk RNA-Seq and
ATAC-Seq for mouse and human samples, including fully documented and rigorous quality controls and
support for experimental design and planning. (3) To effectively and seamlessly interface with postdocs,
technicians, epidemiologists and PIs from the Clinical Core C and from each of the four projects, including
sample shipping, receiving, thawing, data processing, visualization and delivery. To provide these services, we
have built a team of wet lab technicians, bioinformaticians and computational biologists. Interfaces with all
projects and core C are established and working well.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism of kindlin-3-dependent integrin activation
-
批准号:10676897
-
项目类别:
-
资助金额:$54.92万
-
财政年份:2020
-
负责人:Klaus F. Ley
-
依托单位:
Mechanism of kindlin-3-dependent integrin activation
-
批准号:10229369
-
项目类别:
-
资助金额:$54.93万
-
财政年份:2020
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:10112954
-
项目类别:
-
资助金额:$90.72万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:10369710
-
项目类别:
-
资助金额:$58.9万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:9895858
-
项目类别:
-
资助金额:$90.7万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:10623034
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:10565907
-
项目类别:
-
资助金额:$76.97万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Core E: Cell sorting, CyTOF and RNA-Seq
-
批准号:10188604
-
项目类别:
-
资助金额:$54.45万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
Super-resolution confocal microscope
-
批准号:9274885
-
项目类别:
-
资助金额:$56.63万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
ApoB-specific CD4 T cells in mouse and human atherosclerosis
-
批准号:10188608
-
项目类别:
-
资助金额:$38.98万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
Project 4: APOB-specific CD4 and CD8 T cells exacerbate atherosclerosis
-
批准号:10334097
-
项目类别:
-
资助金额:$4.3万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
Vaccination with MHC-II restricted ApoB100 peptides to prevent atherosclerosis
-
批准号:8819012
-
项目类别:
-
资助金额:$45.55万
-
财政年份:2014
-
负责人:Klaus F. Ley
-
依托单位:
Vaccination with MHC-II restricted ApoB100 peptides to prevent atherosclerosis
-
批准号:8966694
-
项目类别:
-
资助金额:$43.63万
-
财政年份:2014
-
负责人:Klaus F. Ley
-
依托单位:
VASCULATA 2013: Vascular Immunology
-
批准号:8597858
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2013
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions with T cells in atherosclerosis
-
批准号:8675936
-
项目类别:
-
资助金额:$42.48万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions in atherosclerosis
-
批准号:9311933
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions with T cells in atherosclerosis
-
批准号:8346057
-
项目类别:
-
资助金额:$56.61万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions with T cells in atherosclerosis
-
批准号:8499418
-
项目类别:
-
资助金额:$43.3万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions with T cells in atherosclerosis
-
批准号:9065736
-
项目类别:
-
资助金额:$43.35万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Cell Phenotyping Core
-
批准号:8703257
-
项目类别:
-
资助金额:$10.93万
-
财政年份:2008
-
负责人:Klaus F. Ley
-
依托单位:
海外基金